©The Author(s) 2025.
World J Gastroenterol. Dec 28, 2025; 31(48): 112972
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.112972
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.112972
Table 2 Performance of serum uric acid to high-density lipoprotein cholesterol ratio and conventional biomarkers in predicting intermediate/high cardiovascular risk by Framingham risk score, %
| Variables | AUC | 95%CI | Sensitivity | Specificity | Optimal cutoff | P value |
| UHR | 0.655 | (0.635, 0.674) | 61.4 | 62.5 | 291.739 | < 0.0001 |
| SUA | 0.626 | (0.607, 0.646) | 62.6 | 56.7 | 350.650 | < 0.0001 |
| HDL-C | 0.617 | (0.598, 0.637) | 55.6 | 64.8 | 1.195 | < 0.0001 |
| TG | 0.597 | (0.577, 0.617) | 52.9 | 61.1 | 1.815 | < 0.0001 |
- Citation: Wang Y, Ma GH, Qu MY, Xu QS, Huang HX. Serum uric acid-to-high-density lipoprotein cholesterol ratio and cardiovascular risk in Asian patients with metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(48): 112972
- URL: https://www.wjgnet.com/1007-9327/full/v31/i48/112972.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i48.112972